astragaloside a has been researched along with 1-methyl-4-phenylpyridinium in 1 studies
| Studies (astragaloside a) | Trials (astragaloside a) | Recent Studies (post-2010) (astragaloside a) | Studies (1-methyl-4-phenylpyridinium) | Trials (1-methyl-4-phenylpyridinium) | Recent Studies (post-2010) (1-methyl-4-phenylpyridinium) |
|---|---|---|---|---|---|
| 675 | 5 | 573 | 1,854 | 1 | 593 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, GD; Li, LH; Qin, HZ; Wang, JL; Wu, L; Xia, Y; Yang, JD; Yao, LB; Zhang, J; Zhang, ZG | 1 |
1 other study(ies) available for astragaloside a and 1-methyl-4-phenylpyridinium
| Article | Year |
|---|---|
Astragaloside IV prevents MPP⁺-induced SH-SY5Y cell death via the inhibition of Bax-mediated pathways and ROS production.
Topics: 1-Methyl-4-phenylpyridinium; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cell Line, Tumor; Cell Survival; Dopaminergic Neurons; Gene Expression Regulation; Humans; Neuroblastoma; Parkinson Disease; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Saponins; Triterpenes | 2012 |